An interventional study of fish oil supplementation in Hemodialysis and End Stage Renal Disease, sponsored by Laboratoire Régional de Nutrition Humaine. Completed at 1 site in France. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2016-03-03.
Sponsored by Laboratoire Régional de Nutrition Humaine · Not applicable, Interventional, and Screening
The aim of the study was to determine the effects of a 3-week fish oil oral supplementation on the metabolic fate and thermogenic effect of an oral glucose load in hemodialysis patients.
3,840 studies on the registry are indexed under Kidney Diseases; 500 are open to participants now.
This study's enrollment of 8 is below the median of 70 across 2,640 interventional studies indexed under Kidney Diseases.
Browse Kidney Diseases studies →This is the only study on the registry with Laboratoire Régional de Nutrition Humaine as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
plasma glucose utilization
glucose-induced thermogenesis
This study is completed, as verified in Feb 2007. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.